Abonnez-vous pour accéder à l'ensemble des données
Entreprise Secteur d'activité Cap. boursière (USDm) # acheteurs nets Valeur nette ($) % du flottant acheté % d'actions détenues par les initiés
Pharmaceuticals & Medical Research Mega (1.0tn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Mega (653.5bn) -1–5 -$10M–$100M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals & Medical Research Mega (443.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (371.7bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Mega (358.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (313.6bn) 0 Aucune activité — —
CH Novartis AG (NOVN)
Pharmaceuticals & Medical Research Mega (306.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (254.2bn) 1–5 $10M–$100M 0–15% 0–15%
Healthcare Services Mega (239.8bn) -1–5 -$10M–$100M -0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals & Medical Research Mega (237.5bn) -1–5 -$1M–$10M -0–15% 0–15%
DK Novo Nordisk A/S (NOVO-B)
Pharmaceuticals & Medical Research Mega (201.4bn) 0 Aucune activité — 0–15%
Healthcare Services Large (197.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (181.4bn) 0 Aucune activité — 0–15%
US Pfizer Inc (PFE)
Pharmaceuticals & Medical Research Large (162.7bn) 1–5 $1M–$10M 0–15% 0–15%
US Danaher Corp (DHR)
Healthcare Services Large (151.8bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (137.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (132.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (132.1bn) 0 Aucune activité — 0–15%
Healthcare Services Large (131.4bn) 0 Aucune activité — 0–15%
Healthcare Services Large (119.9bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (107.4bn) 0 Aucune activité — 0–15%
US Stryker Corp (SYK)
Healthcare Services Large (105.6bn) -1–5 -$100M+ -0–15% 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals & Medical Research Large (104.9bn) 0 Aucune activité — 0–15%
GB GSK plc (GSK)
Pharmaceuticals & Medical Research Large (97.6bn) 11–20 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (92.5bn) 0 Aucune activité — 15–50%
AU CSL Ltd (CSL)
Pharmaceuticals & Medical Research Large (90.6bn) 0 Aucune activité — 0–15%
Healthcare Services Large (90.0bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (84.8bn) 0 Aucune activité — 0–15%
US Celgene Corp (CELG)
Pharmaceuticals & Medical Research Large (77.0bn) 0 Aucune activité — —
Healthcare Services Large (74.8bn) 0 Aucune activité — 0–15%
Healthcare Services Large (69.3bn) 1–5 $1M–$10M 0–15% 0–15%
NL argenx SE (ARGX)
Pharmaceuticals & Medical Research Large (67.1bn) -6–10 -$10M–$100M -0–15% 0–15%
US Allergan plc (AGN)
Pharmaceuticals & Medical Research Large (63.7bn) 0 Aucune activité — 0–15%
US Cencora Inc (COR)
Healthcare Services Large (61.2bn) -1–5 -$1M–$10M -0–15% 0–15%
US Moderna Inc (MRNA)
Pharmaceuticals & Medical Research Large (60.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (58.2bn) 0 Aucune activité — 0–15%
DE Bayer AG (BAYN)
Pharmaceuticals & Medical Research Large (55.1bn) 1–5 $1M–$10M 0–15% —
Healthcare Services Large (51.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (51.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (50.0bn) -1–5 -$1M–$10M -0–15% 0–15%
BE Ucb SA (UCB)
Pharmaceuticals & Medical Research Large (49.4bn) 1–5 $100K–$1M 0–15% 15–50%
US Humana Inc (HUM)
Healthcare Services Large (48.1bn) 0 Aucune activité — 0–15%
Healthcare Services Large (44.7bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Large (44.0bn) -6–10 -$10M–$100M -0–15% 0–15%
US Medline Inc (MDLN)
Healthcare Services Large (43.8bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Large (43.6bn) -1–5 -$1M–$10M -0–15% 0–15%
US Seagen Inc (SGEN)
Pharmaceuticals & Medical Research Large (43.2bn) 0 Aucune activité — 0–15%
Healthcare Services Large (42.3bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Large (42.3bn) -1–5 -$100K–$1M -0–15% 0–15%
US Waters Corp (WAT)
Healthcare Services Large (41.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (39.9bn) -1–5 -$1M–$10M -0–15% 0–15%
GB Haleon PLC (HLN)
Pharmaceuticals & Medical Research Large (39.7bn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals & Medical Research Large (39.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (38.3bn) 0 Aucune activité — 0–15%
US Illumina Inc (ILMN)
Healthcare Services Large (34.6bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Large (33.4bn) 0 Aucune activité — 0–15%
US Resmed Inc (RMD)
Healthcare Services Large (33.4bn) 0 Aucune activité — 0–15%
US Centene Corp (CNC)
Healthcare Services Large (32.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (32.0bn) 0 Aucune activité — 50%+
US Biogen Inc (BIIB)
Pharmaceuticals & Medical Research Large (31.9bn) -1–5 -$100K–$1M -0–15% 0–15%
US DexCom Inc (DXCM)
Healthcare Services Large (31.9bn) 0 Aucune activité — 0–15%
Healthcare Services Large (31.9bn) 0 Aucune activité — 0–15%
CH Alcon AG (ALC)
Healthcare Services Large (30.8bn) 0 Aucune activité — 0–15%
US Zoetis Inc (ZTS)
Pharmaceuticals & Medical Research Large (30.2bn) 0 Aucune activité — 0–15%
Healthcare Services Large (29.1bn) 1–5 < $100K 0–15% 15–50%
US Cerner Corp (CERN)
Healthcare Services Large (27.9bn) 0 Aucune activité — 0–15%
US Insmed Inc (INSM)
Pharmaceuticals & Medical Research Large (27.8bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (27.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (26.8bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Large (26.6bn) 0 Aucune activité — 0–15%
Healthcare Services Large (26.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (26.1bn) -1–5 -$1M–$10M -0–15% 50%+
Pharmaceuticals & Medical Research Large (25.2bn) -6–10 -$100M+ -0–15% 15–50%
DE Biontech SE (BNTX)
Pharmaceuticals & Medical Research Large (24.8bn) -1–5 -$10M–$100M -0–15% 50%+
US Incyte Corp (INCY)
Pharmaceuticals & Medical Research Large (24.8bn) -1–5 -$10M–$100M -0–15% 0–15%
US Steris Ltd (STE)
Healthcare Services Large (23.9bn) 0 Aucune activité — 0–15%
Healthcare Services Large (23.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (23.5bn) -6–10 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (23.2bn) 1–5 $100K–$1M 0–15% 15–50%
IE STERIS plc (STE)
Healthcare Services Large (23.2bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (21.7bn) -11–20 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (21.3bn) -1–5 -$100K–$1M -0–15% 0–15%
DK Genmab A/S (GMAB)
Pharmaceuticals & Medical Research Large (21.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (20.3bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (20.0bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (19.4bn) 0 Aucune activité — 50%+
Healthcare Services Large (18.9bn) -1–5 -$100K–$1M -0–15% 0–15%
US Viatris Inc (VTRS)
Pharmaceuticals & Medical Research Large (18.6bn) 0 Aucune activité — 0–15%
Healthcare Services Large (18.4bn) 0 $100K–$1M 0–15% 15–50%
Healthcare Services Large (18.0bn) 0 Aucune activité — 15–50%
Healthcare Services Large (17.9bn) 0 Aucune activité — 50%+
Pharmaceuticals & Medical Research Large (17.2bn) -6–10 -$100M+ -0–15% 15–50%
US ABIOMED Inc (ABMD)
Healthcare Services Large (17.2bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (17.1bn) -1–5 -$100K–$1M -0–15% 0–15%
US Hologic Inc (HOLX)
Healthcare Services Large (16.9bn) 0 Aucune activité — 0–15%
Pharmaceuticals & Medical Research Large (16.6bn) -6–10 -$10M–$100M -0–15% 0–15%
FR Ipsen SA (IPN)
Pharmaceuticals & Medical Research Large (16.2bn) 1–5 < $100K 0–15% 50%+
Pharmaceuticals & Medical Research Large (16.0bn) 0 Aucune activité — 0–15%
IN Cipla Ltd (CIPLA)
Pharmaceuticals & Medical Research Large (15.9bn) 0 Aucune activité — 15–50%
Pharmaceuticals & Medical Research Large (15.7bn) 0 Aucune activité — 0–15%